A pulse of supply and production issues caused by the COVID-19 crisis is making its way through the dietary supplement industry. Inventories of botanical ingredients continue to hold up, but unprecedented demand for immunity boosting products is causing...
As the grip of the COVID-19 outbreak begins to extend more seriously beyond China, there have been mixed messages about the impact of the virus on the nutritional supplements industry. Are we at panic stations – or is it more a case of business as usual?
After more than a year-long slump, China’s important vitamin A market is finally starting to rebound, with prices expected to continue to grow until the second-half 2016, according to market analyst CCM.
Chinese infant formula manufacturer Biostime International Holdings has entered into a Framework Agreement with Isigny Sainte Mère (ISM) to finance an expansion of the French firm’s infant formula production capacity.
DSM has upped its full-year profit forecast by €100m to almost €1bn after recording its strongest ever quarter on the back of a robust performance from its Nutrition cluster, and in particular its vitamins portfolio.
'Tis the season for stocking up for Christmas. But after a year of rising food prices and other factors affecting supply certain seasonal ingredients, it may cost a little more to make the table groan under the weight edible goodies.
Colloides Naturels International targets natural market demand with a combination of a wheat fibre and an acacia gum fibre that provides non-soluble and soluble fibre for a wide variety of food applications.
Raisio has announced an expansion of its Finnish production
facility to meet growing demand in Asia of its cholesterol lowering
Benecol ingredient - as part of a bid to turn around declining
profits in the sector.
Compound Solutions has entered into an exclusive agreement for
distribution of Chinese-sourced CoQ10 - potentially further
relieving tight supply of while generating more competition between
Chinese and Japanese sources.
China's dominance of the vitamin C market was confirmed last week
as DSM halted all production of the bulk vitamin in the US, making
its Dalry plant in Scotland the only remaining major plant outside
Japanese firm Kyowa Hakko Kogyo will begin marketing a refined
version of Cargill's vegetarian glucosamine on its home market next
month, to meet steadily rising demand for quality forms of the
joint health ingredient.
Shareholders who have become aware of an omega-6 mountain in the
stockrooms of Martek customers have filed a lawsuit seeking class
action status against the company, alleging that it flooded
customers with inventory in order to meet...
A contract manufacturer of pharmaceutical ingredients could provide
supplement makers with new supplies of the antioxidant coenzymeQ10,
currently selling for record prices owing to tight supply,
reports Dominique Patton.
The U.S. ethical nutrition market is divided into four very
distinct categories: the infant formula market, adult enteral
formula, parenteral formula and ethical nutrition supplies and